These pro-osteogenic markers are balanced by inhibitors of calcification including MGP, osteopontin, BMP-7, and fetuin A.33Decreased fetuin A and MGP levels are both found in CKD patients and low levels of inhibitors in patients are associated with increased risk of death.34 This evidence concerns the gene AHSG and chronic kidney disease.